Featured Research

from universities, journals, and other organizations

The hitch in the drug? The itch in the drug: Scientists discover clue to ending chronic itching side effect of certain drugs

Date:
February 9, 2011
Source:
University of California - San Diego
Summary:
Scratching deep beneath the surface, a team of researchers the U.S. and South Korea have identified two distinct neuronal signaling pathways activated by a topical cream used to treat a variety of skin diseases. One pathway produces the therapeutic benefit; the other induces severe itching as a side effect.

Scratching deep beneath the surface, a team of researchers from the University of California, San Diego School of Medicine and three South Korean institutions have identified two distinct neuronal signaling pathways activated by a topical cream used to treat a variety of skin diseases. One pathway produces the therapeutic benefit; the other induces severe itching as a side effect.

The findings, published in the Proceedings of the National Academy of Sciences, point to the possibility of designing future drugs that effectively treat targeted conditions while blocking the cellular signals that can lead to problematic itching and scratching.

"This new pathway provides another avenue to block the scratching response that appears as a chronic side effect during treatments of cancer, renal failure or the use of some antibiotics," said Melvin I. Simon, PhD, an adjunct professor in the UCSD Department of Pharmacology and a corresponding co-author of the study, headed by Sang-Kyou Han, an adjunct assistant professor at UC San Diego.

Itching -- and the scratching response -- are part of a complex and imperfectly understood somatosensory process that includes complex, confounding psychological factors. The mechanisms involved are so sophisticated, said Simon, that just reading or thinking about itching can provoke the sensation.

Improving understanding of itch biology isn't just a matter of scratching an intellectual curiosity. It could lead to practical medical benefits, according to Simon. "Itching and scratching are side effects of a variety of therapeutic drugs and of specific illnesses. In many cases, these effects are severe and make it impossible to use otherwise effective therapies. Thus, the itch remains an unmet medical need."

In the PNAS study, the scientists focused on Imiquimod (marketed as Aldara), a prescription-based topical cream used to treat a number of skin diseases, including some forms of skin cancer, by activating the body's innate immune response. One major side effect: Imiquimod produces intense itching and scratching.

The researchers discovered that the skin sensory circuit activated by Imiquimod to causes itching is different from the signaling pathway involved in the drug's therapeutic benefit. Indeed, the Imiquimod itch mechanism is distinct from other, well-defined itch mechanisms.

"By breaking down the response and sorting out its various elements, it may be possible to both understand the molecular mechanisms involved and to control them," said Simon, who noted more research is planned.

Co-authors of the paper are Se-Jeong Kim of UCSD's Department of Pharmacology and the Department of Neuroscience, Dental Research Institute and Brain Korea21, School of Dentistry, Seoul National University; Goon Ho Park, Hyejung Min and Estelle Wall, UCSD Department of Pharmacology; Donghoon Him and Sung Joong Lee, Department of Neuroscience, Dental Research Institute and Brain Korea21, School of Dentistry, Seoul National University; Jaekwang Lee and C. Justin Lee of the Center for Functional Connectomics, Korea Institute of Science and Technology.


Story Source:

The above story is based on materials provided by University of California - San Diego. The original article was written by Scott LaFee. Note: Materials may be edited for content and length.


Journal Reference:

  1. S.-J. Kim, G. H. Park, D. Kim, J. Lee, H. Min, E. Wall, C. J. Lee, M. I. Simon, S. J. Lee, S.-K. Han. Analysis of cellular and behavioral responses to imiquimod reveals a unique itch pathway in transient receptor potential vanilloid 1 (TRPV1)-expressing neurons. Proceedings of the National Academy of Sciences, 2011; DOI: 10.1073/pnas.1019755108

Cite This Page:

University of California - San Diego. "The hitch in the drug? The itch in the drug: Scientists discover clue to ending chronic itching side effect of certain drugs." ScienceDaily. ScienceDaily, 9 February 2011. <www.sciencedaily.com/releases/2011/02/110208164001.htm>.
University of California - San Diego. (2011, February 9). The hitch in the drug? The itch in the drug: Scientists discover clue to ending chronic itching side effect of certain drugs. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2011/02/110208164001.htm
University of California - San Diego. "The hitch in the drug? The itch in the drug: Scientists discover clue to ending chronic itching side effect of certain drugs." ScienceDaily. www.sciencedaily.com/releases/2011/02/110208164001.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Xtreme Eating: Your Daily Caloric Intake All On One Plate

Xtreme Eating: Your Daily Caloric Intake All On One Plate

Newsy (July 30, 2014) The Center for Science in the Public Interest released its 2014 list of single meals with whopping calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins